Nitrosatable drug exposure during pregnancy and risk of stillbirth.

Anne Marie Ladehoff Thomsen Zeyan Liew Anders Hammerich Riis Leslie Thomas Stayner Cecilia Høst Ramlau-HansenTorben SigsgaardJørn Olsen

Published in: Pharmacoepidemiology and drug safety (2019)

Nitrosatable drug use during the first 22 weeks of pregnancy might increase risk of stillbirth. The findings should be interpreted cautiously because of important unmeasured factors that might influence the observed association, including maternal vitamin C intake, dietary, and other sources of nitrate/nitrite intake.

Keyphrases

nitric oxide
drinking water
pregnancy outcomes
weight gain
birth weight
preterm birth
gestational age
emergency department
adverse drug